We are live on ! Find out more
S

Sanofi Portfolio holdings

AUM $336M
1-Year Est. Return 126.85%
This Fund
S&P 500
This Quarter Est. Return
+42.18%
1 Year Est. Return
+126.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
+$50.1M
Cap. Flow
+$680K
Cap. Flow %
0.22%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
MPLT
MapLight Therapeutics
MPLT
+$15.3M

Top Sells

Rank Stock Value
1
OMDA
Omada Health Inc
OMDA
+$11.6M
2
LVTX
LAVA Therapeutics
LVTX
+$2.99M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGTX icon
1
MeiraGTx Holdings
MGTX
$1.14B
$97M 31.24%
12,197,737
– –
INBX icon
2
Inhibrx
INBX
$1.21B
$91.5M 29.47%
1,157,926
– –
NVAX icon
3
Novavax
NVAX
$1.23B
$46.2M 14.9%
6,880,481
– –
ANAB icon
4
AnaptysBio
ANAB
$1.59B
$39.8M 12.84%
821,917
– –
IMRX icon
5
Immuneering
IMRX
$282M
$17.8M 5.74%
2,708,559
– –
MPLT
6
MapLight Therapeutics
MPLT
$449M
$16M 5.16%
+912,041
New +$15.3M
ELDN icon
7
Eledon Pharmaceuticals
ELDN
$276M
$1.23M 0.4%
814,980
– –
QTTB icon
8
Q32 Bio
QTTB
$452M
$810K 0.26%
244,083
– –
LVTX
9
DELISTED
LAVA Therapeutics
LVTX
– –
-1,919,455
Closed -$2.99M
OMDA
10
Omada Health Inc
OMDA
$1.22B
– –
-524,903
Closed -$11.6M

Similar funds

LFP
Leeward Financial Partners Bellevue, Washington $336M AUM 20.94% 1-Year Est. Return
HFS
Haverford Financial Services Radnor, Pennsylvania $336M AUM 20.46% 1-Year Est. Return
SG
Standard General New York $336M AUM 16.52% 1-Year Est. Return
TH
Team Hewins Redwood City, California $337M AUM 24.42% 1-Year Est. Return
SC
Schiavi & Co Wilmington, Delaware $337M AUM 16.69% 1-Year Est. Return
SIC
Shoker Investment Counsel Oxford, Ohio $337M AUM 24.9% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
PCM
Passive Capital Management Baltimore, Maryland $335M AUM 12.6% 1-Year Est. Return

Sanofi's Q4 2025 Portfolio in Review

As of Q4 2025, Sanofi held 10 positions worth $310M, up 19% from $260M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sanofi's Q4 2025 filing shows 1 new and 2 closed positions. Its largest new stake was MapLight Therapeutics: 912,041 shares worth $16M. The largest sale was Omada Health Inc, an estimated $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sanofi's largest Q4 2025 buy was MapLight Therapeutics: 912,041 shares worth $16M.
  • Sanofi fully exited Omada Health Inc in Q4 2025, selling an estimated $11.6M.
  • Sanofi's ten largest holdings make up 100% of its $310M portfolio in Q4 2025.
  • Sanofi opened 1 new position and closed 2 in Q4 2025.
  • Sanofi's portfolio value rose 19% quarter-over-quarter to $310M.

Based on Sanofi's 13F filing for Q4 2025, filed 11 Feb 2026.